Eclipse Bioinnovations, Inc. – Trademark Portfolio
Entity Type: 03
Eclipse Bioinnovations, Inc. holds 43 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 33 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include ERIBO, END-SEQ, FLI-SEQ, ECLIPSE BIO, and ECLIPSE BIOINNOVATIONS. The owner is based in San Diego, CA.
#105
6195 Cornerstone Court East
San Diego, CA 92121
Showing of trademarks Trademarks
Trademark Classifications
Eclipse Bioinnovations, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Eclipse Bioinnovations, Inc. have?
Eclipse Bioinnovations, Inc. has 43 U.S. trademarks filed with the USPTO. Of these, 6 registered, 37 abandoned.
What trademark classes does Eclipse Bioinnovations, Inc. file in?
Eclipse Bioinnovations, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Eclipse Bioinnovations, Inc.'s most well-known trademarks?
Eclipse Bioinnovations, Inc.'s registered trademark portfolio includes well-known marks such as ERIBO, END-SEQ, FLI-SEQ, ECLIPSE BIO, and ECLIPSE BIOINNOVATIONS. These are among 6 currently registered trademarks in the portfolio.
What is Eclipse Bioinnovations, Inc.'s trademark registration success rate?
Eclipse Bioinnovations, Inc. has a 14% trademark registration rate, with 6 out of 43 resolved applications resulting in successful registration. Currently, 0 applications are pending review.